Labviva vs Neuralink
Side-by-side comparison of AI visibility scores, market position, and capabilities
Labviva is a digital procurement marketplace for life sciences researchers, connecting labs at academic institutions and biopharma companies with scientific suppliers; raised $22M Series A in 2022;
About
Labviva is a Boston-based life sciences technology company founded in 2017 by Lina Nilsson and Barry Bettman. It operates a digital procurement marketplace purpose-built for scientific researchers at pharmaceutical companies, biotech firms, academic research institutions, and hospitals. The platform aggregates product catalogs from thousands of scientific suppliers — including reagents, lab equipment, consumables, and biological materials — into a unified, searchable interface that integrates directly with institutional procurement and ERP systems such as SAP, Coupa, and Jaggaer. This eliminates the fragmented, email-and-catalog-driven purchasing workflows that dominate scientific procurement.
Pioneer of implantable BCIs with 12+ active human patients as of Sep 2025; raised $650M Series E in Apr 2026 led by ARK Invest and Sequoia at a ~$14.9B valuation; mass production underway.
About
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with paralysis to control digital devices directly with their thoughts. The company's first commercial product, the N1 implant, is a coin-sized device containing 1,024 electrodes that is surgically placed in the motor cortex. As of September 2025, twelve patients worldwide had received the N1 implant and were actively using it to control computers, smartphones, and robotic arms with neural signals alone.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.